Patent Assignment
Reel/Frame 031214/0500
Assignment of Assignor's Interest
Recorded: 2013-09-16
Pages: 74
Assignor
BIOGEN IDEC INTERNATIONAL HOLDING LTD.
Executed: 2013-08-19
Assignee
BIOGEN IDEC MA INC.
14 CAMBRIDGE CENTER, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties
(32)
Blood-Brain Barrier Model
Application:
07/413,274 →
Blood-Brian Barrier Model
Patent:
5,260,210 →
Application:
07/577,650 →
Compositions and Methods for Modulating Leukocyte Adhesion to Brain Endothelial Cells
Application:
07/871,223 →
Compositions and Methods for Modulating Leukocyte Adhesion to Brain Endothelial Cells
Application:
08/402,962 →
Compositions and Methods for Modulating Leukocyte Adhesion to Brain Endothelial Cells
Patent:
6,033,665 →
Application:
08/457,847 →
Administration of agents for the treatment of inflammation
Application:
10/372,111 →
Publication:
US 2004/0009169
Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents
Application:
10/763,424 →
Publication:
US 2005/0069541
Composition for and Treatment of Demyelinating Diseases and Paralysis by Administration of Remyelinating Agents
Immunoglobulin formulation and method of preparation thereof
Application:
10/773,406 →
Publication:
US 2005/0053598
Methods and composition for treating tumors and metastatic disease
Application:
11/049,365 →
Publication:
US 2005/0255118
Steroid sparing agents and methods of using same
Application:
11/095,822 →
Publication:
US 2006/0004019
Steroid sparing agents and methods of using same
Application:
11/096,074 →
Publication:
US 2005/0260193
Administration of Agents for the Treatment of Inflammation
Methods of treating inflammatory and autoimmune diseases with natalizumab
Application:
11/711,628 →
Publication:
US 2007/0207141
Methods of treating inflammatory and autoimmune diseases with natalizumab
Application:
11/713,000 →
Publication:
US 2007/0231319
Immunoglobulin Formulation and Method of Preparation Thereof
Methods of Treating Inflammatory and Autoimmune Diseases with Natalizumab
Administration of Agents for the Treatment of Inflammation
Application:
12/846,350 →
Publication:
US 2011/0064729
Methods of Treating Inflammatory and Autoimmune Diseases with Natalizumab
Method for Treating Multiple Sclerosis and Crohn's Disease
METHODS FOR DETERMINING DIFFERENCES IN ALPHA-4 INTEGRIN ACTIVITY BY CORRELATING DIFFERENCES IN sVCAM AND/OR sMadCAM LEVELS
Application:
13/881,520 →
Publication:
US 2013/0337470
Administration of agents for the treatment of inflammation
Application:
60/360,134 →
Administration of agents for the treatment of inflammation
Application:
60/374,501 →
Reversal of inflammatory response by inhibition of alpha-4 integrin to inhibit demyelination
Application:
60/442,171 →
Immunoglobulin formulation and method of preparation thereof
Application:
60/445,818 →
Reversal of inflammatory response by inhibition of alpha-4 integrin to inhibit demyelination and reverse paralysis
Application:
60/500,316 →
Methods and compositions for treating tumors and metastatic disease
Application:
60/541,946 →
Steroid sparing agents and methods of using same
Application:
60/558,120 →
Steroid sparing agents and methods of using same
Application:
60/558,121 →
Lyophilized immunoglobulin formulations and methods of preparation
Application:
60/929,133 →
Methods for Determining Differences in Alpha-4 Integrin Activity by Correlating Differences in sMadCAM Levels
Application:
61/406,358 →
Methods for Determining Differences in Alpha-4 Integrin Activity by Correlating Differences in sVCAM Levels
Application:
61/406,365 →
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 20, 2011
From: BURKE, DAVID J.; BUCKLEY, SHAUN E.; LEHRMAN, SHERWOOD RUSS; O'CONNOR, BARBARA HORSEY
To: ELAN PHARMACEUTICALS, INC.
Reel/Frame 026157/0276 →
Assignment of Assignor's Interest
Apr 4, 2013
From: ELAN PHARMA INTERNATIONAL LIMITED
To: BIOGEN IDEC INTERNATIONAL HOLDING LTD.
Reel/Frame 030155/0822 →
Assignment of Assignor's Interest
Sep 4, 2013
From: CHACKERIAN, ALISSA A.
To: BIOGEN IDEC MA INC.
Reel/Frame 031137/0709 →
Assignment of Assignor's Interest
Sep 16, 2013
From: ELAN PHARMACEUTICALS, INC.
To: BIOGEN IDEC INTERNATIONAL HOLDING LTD.
Reel/Frame 031214/0424 →
Change of Name
May 4, 2015
From: BIOGEN IDEC MA INC.
To: BIOGEN MA INC.
Reel/Frame 035571/0926 →
Assignment of Assignor's Interest
May 17, 2022
From: YEDNOCK, THEODORE A.
To: ELAN PHARMACEUTICALS, INC.
Reel/Frame 059935/0304 →